IGC Pharma, Inc. Earnings Per Share Diluted

Quick Answer

IGC Pharma, Inc. reported Earnings Per Share Diluted of $0.09 (loss) per share for the year ending 2025.

  • IGC Pharma, Inc. showed an increase of +59.1% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from IGC Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on June 27, 2025.
  • XBRL data for this metric is available from 2011 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2010: $0.05 (loss) per share | Q2 2011: $0.04 (loss) per share | Q3 2011: $0.04 (loss) per share | Q4 2011: $0.09 (loss) per share | Q2 2012: $0.14 (loss) per share | Q3 2012: $0.02 (loss) per share | Q4 2012: $0.05 per share | Q2 2013: $0.09 (loss) per share | Q3 2013: $0.09 (loss) per share | Q4 2013: $0.04 (loss) per share | Q2 2014: $0.12 (loss) per share | Q3 2014: $0.07 (loss) per share | Q4 2014: $0.05 (loss) per share | Q2 2015: $0.03 (loss) per share | Q3 2015: $0.04 (loss) per share | Q4 2015: $0.02 (loss) per share | Q2 2016: $0.02 (loss) per share | Q3 2016: $0.02 (loss) per share | Q4 2016: $0.00 per share | Q2 2017: $0.02 (loss) per share | Q3 2017: $0.01 (loss) per share | Q4 2017: $0.02 (loss) per share | Q3 2023: $0.05 (loss) per share | Q4 2023: $0.09 (loss) per share | Q2 2024: $0.03 (loss) per share | Q3 2024: $0.02 (loss) per share | Q4 2024: $0.02 (loss) per share | Q2 2025: $0.02 (loss) per share | Q3 2025: $0.02 (loss) per share.
  • Over the full 9 years of available data (2011 to 2025), IGC Pharma, Inc.'s Earnings Per Share Diluted has grown by 93.3%.
  • Historical annual values: Fiscal year 2025: $0.09 (loss) per share | Fiscal year 2024: $0.22 (loss) per share | Fiscal year 2017: $0.07 (loss) per share | Fiscal year 2016: $0.17 (loss) per share | Fiscal year 2015: $0.31 (loss) per share | Fiscal year 2014: $0.37 (loss) per share | Fiscal year 2013: $0.32 (loss) per share | Fiscal year 2012: $2.66 (loss) per share | Fiscal year 2011: $1.34 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: